Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
111 Inc (YI US)
Watchlist
124
Analysis
Information Technology
•
China
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Tencent Music
•
06 Oct 2018 15:41
ECM Weekly (6 October 2018) - Tencent Music, Aston Martin, Osotspa, China Renaissance
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
Zhen Zhou, Toh
652 Views
Share
bearish
•
Haidilao
•
02 Oct 2018 06:08
Last Week in GER Research: Haidilao, Popflops, Bitmain, Shandong Gold, Niu and China Renaissance
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight 25% potential downside at Haidilao as...
Rickin Thakrar
Follow
558 Views
Share
bearish
•
Meituan
•
24 Sep 2018 06:21
Last Week in GER Research: Meituan, IPO Trading Strategy, Shandong Gold, Maoyan and Viomi
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight that Meituan is closer to fair value...
Rickin Thakrar
Follow
433 Views
Share
bearish
•
111 Inc
•
18 Sep 2018 16:03
111 Inc. (1药网) Trading Update - No Changes to Assumptions; Fairly Valued at Best
111 Inc (YI US) 's debut performance was a stark contrast to NIO Inc (NIO US) despite both pricing at the low end. 111, however, had to downsize...
Zhen Zhou, Toh
464 Views
Share
bearish
•
Meituan
•
17 Sep 2018 06:37
Last Week in GER Research: Meituan, Nio, Haidilao, Shandong Gold, China Renais., X Financial and PDD
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we dig into the economics of Mobike as it relates...
Rickin Thakrar
Follow
476 Views
Share
First
Previous
20
21
22
23
24
25
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x